Mohammed Afshar

Director/Board Member at GENOMIC VISION

Health Technology

Consumer Services

Profile

Mohammed Afshar is the founder of Ariana Pharmaceuticals SA, where he holds the title of Chief Executive Officer & Director starting in 2009.
He is also the founder of RiboTargets Ltd.
Dr. Afshar's current job is as a Member-Supervisory Board at Génomic Vision SA, starting in 2022.
His former job was as a Research Fellow at The University of York.
Dr. Afshar's education includes undergraduate, graduate, and doctorate degrees from Université de Montpellier.

Mohammed Afshar active positions

Companies	Position	Start
GENOMIC VISION	Director/Board Member	2022-07-10
Ariana Pharmaceuticals SA Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France.	Founder	2002-12-31

All active positions of Mohammed Afshar

Former positions of Mohammed Afshar

Companies	Position	End
The University of York	Chief Tech/Sci/R&D Officer	-
RiboTargets Ltd.	Founder	-

See the detail of Mohammed Afshar's experience

Training of Mohammed Afshar

Université de Montpellier

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mohammed Afshar's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
GENOMIC VISION	Health Technology

Private companies	2
RiboTargets Ltd.	Health Technology
Ariana Pharmaceuticals SA Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France.	Health Technology